腫瘍細胞のアミノ酸トランスポーターの発現とそれを標的とした診断と治療への応用の可能性 Expression of Amino Acid Transporters in Cancers and Their Application to Cancer Diagnosis and Therapuitics

この論文にアクセスする

この論文をさがす

著者

    • 金井 好克 KANAI Yoshikatsu
    • 大阪大学 大学院医学系研究科 生体システム薬理学 Division of Bio-system Pharmacology, Department of Pharmacology Graduate School of Medicine, Osaka University

抄録

Amino acid transporters are integrated membrane proteins that provide cells with nutrient amino acids. It is well established that subsets of amino acid transporters are highly expressed in cancers. A system L transporter LAT1 exhibits prominent expression in many cancers and its expression is inversely correlated with prognosis in some cancers. LAT1 is responsible for the uptake of large neutral amino acids including several essential amino acids. Functional coupling with ASCT2 which is also upregulated in cancers seems beneficial for LAT1 to be driven by intracellular glutamine accumulated by ASCT2 via an exchange mechanism. Now it has been demonstrated that a LAT1- selective ligand, L-[3-18F]-α-methyltyrosine (18F-FMT), is accumulated selectively in cancers in humans in a positron emission tomography (PET) in LAT1-depndent manner. [18F]FMT-PET can be a realistic diagnostic tool in the future. As expected from the roles of LAT1 in cancers, the inhibition of LAT1 results in the suppression of cancers. The newly developed high-affinity inhibitors of LAT1 are expected with therapeutic usefulness.

収録刊行物

  •  

    膜 33(3), 108-117, 2008-05-01 

    THE MEMBRANE SOCIETY OF JAPAN

参考文献:  30件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

各種コード

  • NII論文ID(NAID)
    10021167462
  • NII書誌ID(NCID)
    AN0023215X
  • 本文言語コード
    JPN
  • 資料種別
    REV
  • ISSN
    03851036
  • NDL 記事登録ID
    9525565
  • NDL 雑誌分類
    ZR2(科学技術--生物学--生化学)
  • NDL 請求記号
    Z18-1127
  • データ提供元
    CJP書誌  NDL  J-STAGE 
ページトップへ